Risultati della ricerca - A. Slaughter

A public health approach to monitoring HIV with resistance to HIV pre-exposure prophylaxis. di Susan E Buskin, Richard J Lechtenberg, Francis A Slaughter, Joshua T Herbeck, Roxanne P Kerani, Matthew R Golden, Julia C Dombrowski

Testo

P46 SEER-MEDICARE DATABASE: REAL-WORLD TREATMENTS AND OUTCOMES IN PATIENTS WITH LENALIDOMIDE-REFRACTORY RELAPSED MULTIPLE MYELOMA TREATED WITH 1–3 PRIOR LINES OF THERAPY, INCLUDING... di H. Einsele, B. Dhakal, R. Potluri, J. Schecter, W. Deraedt, N. Lendvai, A. Slaughter, C. Lonardi, S. Nair, J. He, J. Voelker, P. Cost, S. Valluri, F. Yalniz, L. Pacaud, K. Yong

Testo

P899: REAL-WORLD ASSESSMENT OF TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH LENALIDOMIDE-REFRACTORY RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE OPTUM DATABASE di B. Dhakal, H. Einsele, R. Potluri, J. Schecter, W. Deraedt, N. Lendvai, A. Slaughter, C. Lonardi, S. Nair, J. He, N. Joseph, P. Cost, S. Valluri, F. Yalniz, L. Pacaud, K. Yong

Testo

P35 ANALYSIS OF DARATUMUMAB CLINICAL TRIALS: CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH LENALIDOMIDE-REFRACTORY RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH 1-3 PRIOR LINES... di H. Einsele, B. Dhakal, J. M. Schecter, T. Roccia, W. Deraedt, N. Lendvai, A. Slaughter, C. Lonardi, K. Connors, K. Qi, A. Londhe, R. Carson, J. Voelker, P. Cost, S. Valluri, E. Florendo, L. Pacaud, K. Yong

Testo

P36 | EFFECTIVENESS OF BRIDGING THERAPY CORRESPONDS TO IMPROVED OUTCOMES AFTER CILTACABTAGENE AUTOLEUCEL: PHASE 3 CARTITUDE-4 STUDY OF PATIENTS WITH RELAPSED, LENALIDOMIDE-REFRACT... di E. Zamagni, B. Dhakal, S. Iida, M.H. Sidiqi, S.S. Yoon, N. Callander, C. Touzeau, Q. Li, A. Balogh, A. Slaughter, N. Benachour, C. Lonardi, A. Ghosh, M. Vogel, N. Lendvai, T. Lengil, M. Koneru, N. Patel, O. Costa Filho, V. Mahajan, J. Martínez-López, K. Yong, K. Weisel, X. Leleu

Testo

DP110 | INFECTIONS AND IMMUNE RECONSTITUTION IN THE PHASE 3 CARTITUDE-4 TRIAL OF CILTACABTAGENE AUTOLEUCEL VS STANDARD CARE IN LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA AND 1–3 PRIO... di R. Mina, M. Vogel, N.W.C.J. Van De Donk, J. Martínez-López, B. Dhakal, M. Dutka, L. Shune, C. Touzeau, X. Leleu, Y.C. Cohen, W. Alsdorf, K. Li, M. Zhao, Q. Li, A. Ghosh, N. Lendvai, A. Slaughter, C. Lonardi, V. Plaks, M. Koneru, N. Patel, E. Florendo, A. Oriol, R. Popat, P.J. Ho

Testo

P48 | LONG-TERM PROGRESSION-FREE SURVIVAL BENEFIT WITH CILTACABTAGENE AUTOLEUCEL IN STANDARD-RISK RELAPSED/REFRACTORY MULTIPLE MYELOMA di D. Dytfeld, L.J. Costa, A. Oriol, S. Manier, P.M. Voorhees, Y. Lin, M. Htut, W. Roeloffzen, P. J. Ho, U. Shah, M. Zhao, Q. Li, A. Balogh, K. Li, A. Slaughter, N. Benachour, C. Lonardi, A. Ghosh, H. Sun, N. Lendvai, T. Lengil, N. Patel, M. Koneru, E. Florendo, O. Costa Filho, V. Mahajan, P. Rodríguez-Otero, C. Strouse, A.K. Stewart, S. Sidana

Testo